Risk Factors for Sepsis and Pulmonary Embolism Mortality in Burn Patients by Using a Competing Risk Model: A Machine Learning Approach

Biomed Res Int. 2026;2026(1):e7224574. doi: 10.1155/bmri/7224574.ABSTRACTINTRODUCTION: Severe burn injury remains a prevalent cause of morbidity and mortality over the last several decades. Various potential complications significantly contribute to mortality in burn patients. Sepsis and pulmonary e

F Fatemeh Javanmardi

Trends in adipokine-related studies in cardiovascular disease: A bibliometric analysis from 2002 to 2024

Med J Malaysia. 2026 Jul;81(4):593-599.ABSTRACTINTRODUCTION: Adipokines are bioactive proteins secreted by adipose tissue and are increasingly recognised for their role in obesity, inflammation, metabolic dysfunction, and cardiovascular disease (CVD). As research on adipokines and CVD has expanded o

S S Sunita

Determinants of self-care and psychosocial readiness among hypertensive patients: Implications for nursing in low-resource settings

Med J Malaysia. 2026 Jul;81(4):577-585.ABSTRACTINTRODUCTION: Self-care behaviour, motivation, and selfefficacy represent related but distinct dimensions of hypertension self-management. Previous Indonesian studies have generally examined self-care behaviour as the primary outcome or treated motivati

N N P A R Dewi

Ethnicity-specific polygenic risk score for predicting coronary heart disease mortality in Malaysian patients with type 2 diabetes

Med J Malaysia. 2026 Jul;81(4):554-563.ABSTRACTINTRODUCTION: Polygenic risk scores (PRS) are used to aggregate single-nucleotide polymorphisms (SNPs) effects across the genome to estimate an individual's risk of coronary heart disease (CHD). However, most PRS models were developed mainly in Caucasia

K K A Zarkasi

Diagnostic accuracy of zero Coronary Artery Calcium (CAC) score in a Malaysian cohort: A 20-year retrospective analysis

Med J Malaysia. 2026 Jul;81(4):447-454.ABSTRACTINTRODUCTION: The Agatston coronary artery calcium (CAC) score is a widely used screening tool. However, its negative predictive value (NPV) in the Southeast Asian population, prone to premature non-calcified atherosclerosis, is not well defined.MATERIA

J J T Lee

Clinical characteristics and outcomes of myocardial infarction, stroke, and cardiovascular mortality among patients undergoing complex high-risk indicated percutaneous coronary intervention: A one-year review in a single non-surgical centre

Med J Malaysia. 2026 Jul;81(4):430-437.ABSTRACTINTRODUCTION: Complex High-risk Indicated Percutaneous Coronary Intervention (CHIP-PCI) addresses complex coronary artery disease in patients unsuitable for or declining surgery. Performing CHIP-PCI in non-surgical centres presents unique challenges req

Y Y Shen

HFpEF in Asia: Distinct Phenotypes, Shared Mechanisms, and Emerging Insights

JACC Asia. 2026 Aug 6:S2772-3747(26)00531-4. doi: 10.1016/j.jacasi.2026.06.030. Online ahead of print.ABSTRACTHeart failure with preserved ejection fraction (HFpEF) is a heterogeneous, comorbidity-driven syndrome of increasing global prevalence, with Asian patients displaying a distinctive and clini

E Elena Alina Balasa

Cardiac Remodeling Trajectory and Renal Stage-Specific Risk Stratification in East Asian Fabry Disease Patients

JACC Asia. 2026 Aug 6:S2772-3747(26)00528-4. doi: 10.1016/j.jacasi.2026.06.028. Online ahead of print.ABSTRACTBACKGROUND: Static anatomical assessments may not fully capture the dynamic progression and varied clinical outcomes in Fabry cardiomyopathy.OBJECTIVES: The authors aimed to evaluate the pro

Y Yanjia Chen

Lifestyle and Metabolic Health, Low-Grade to Clinically Elevated Albuminuria, and Cardiovascular-Renal Diseases

JACC Asia. 2026 Aug 6:S2772-3747(26)00533-8. doi: 10.1016/j.jacasi.2026.06.032. Online ahead of print.ABSTRACTBACKGROUND: Albuminuria from low-grade to clinically elevated range confers cardiorenal risks.OBJECTIVES: The authors aimed to investigate the differential roles of lifestyle/metabolic facto

Y Yi Ding

Seeking the Sweet Spot in Targeting Cardiovascular Inflammation

No abstractJ Am Coll Cardiol. 2026 Aug 3:S0735-1097(26)07040-3. doi: 10.1016/j.jacc.2026.06.040. Online ahead of print.NO ABSTRACTPMID:42584384 | DOI:10.1016/j.jacc.2026.06.040

P Peter Libby

Intravenous Nicorandil in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary PCI: The CLEAN Randomized Clinical Trial

J Am Coll Cardiol. 2026 Jul 30:S0735-1097(26)07071-3. doi: 10.1016/j.jacc.2026.07.005. Online ahead of print.ABSTRACTBACKGROUND: Nicorandil, an adenosine triphosphate-sensitive potassium-channel opener with nitrate-like properties, may reduce reperfusion injury and microvascular obstruction in ST-se

D Dong Huang

Implications of the 2026 Versus 2018 ACC/AHA Multisociety Dyslipidemia Guidelines on the Clinical Care of U.S. Adults

J Am Coll Cardiol. 2026 Jul 29:S0735-1097(26)07037-3. doi: 10.1016/j.jacc.2026.06.037. Online ahead of print.ABSTRACTBACKGROUND: The American College of Cardiology and American Heart Association recently updated their guidelines for dyslipidemia, which included recommending new risk calculators and

A Ahmed Sayed

Beyond Short-Term Risk: A New Framework for Cardiovascular Prevention

No abstractJ Am Coll Cardiol. 2026 Jul 28:S0735-1097(26)07185-8. doi: 10.1016/j.jacc.2026.07.018. Online ahead of print.NO ABSTRACTPMID:42584381 | DOI:10.1016/j.jacc.2026.07.018

M Michelle L O'Donoghue

Rethinking Disease Progression in Transthyretin Amyloid Cardiomyopathy: Toward Mechanism-Specific Monitoring and Therapeutic Response Assessment

J Am Coll Cardiol. 2026 Aug 4:S0735-1097(26)07249-9. doi: 10.1016/j.jacc.2026.07.026. Online ahead of print.ABSTRACTThe therapeutic landscape of transthyretin amyloid cardiomyopathy has evolved rapidly, with the introduction of transthyretin stabilizers and gene-silencing therapies, together with th

M Marianna Fontana

Comparable 4-Year Stability for High-Sensitivity C-Reactive Protein and LDL Cholesterol

No abstractJ Am Coll Cardiol. 2026 Aug 4:S0735-1097(26)07259-1. doi: 10.1016/j.jacc.2026.07.027. Online ahead of print.NO ABSTRACTPMID:42584379 | DOI:10.1016/j.jacc.2026.07.027

A Ask T Nordestgaard

p.(V142I)-Associated Variant Transthyretin Amyloid Cardiomyopathy Complicating Complex Congenital Heart Disease: A Lethal Combination

JACC Case Rep. 2026 Aug 12:109784. doi: 10.1016/j.jaccas.2026.109784. Online ahead of print.ABSTRACTBACKGROUND: p.(V142I)-associated variant transthyretin amyloid cardiomyopathy (ATTRv-CM) is biologically aggressive and predominantly affects individuals of African ancestry.CASE SUMMARY: A 51-year-ol

Z Zafraan Zathar

Heterologous Expression, Antihypertensive Effect, and Underlying Mechanism of Sequence-Designed ACE Inhibitory Peptide YWLKP

J Agric Food Chem. 2026 Aug 12;74(31):24457-24476. doi: 10.1021/acs.jafc.6c08999.ABSTRACTRational sequence optimization is essential for transforming food-derived peptides into more potent angiotensin-converting enzyme (ACE) inhibitors. LYPVK and its sequence-designed derivative YWLKP exhibit potent

Q Qingping Liang

Thrombolysis in Patients With Mild Ischemic Stroke: A Comparative Effectiveness Study From the Norwegian Stroke Registry

Eur J Neurol. 2026 Aug;33(8):e70734. doi: 10.1111/ene.70734.ABSTRACTBACKGROUND: Intravenous thrombolytic therapy (IVT) is recommended for patients with acute ischemic stroke (AIS) and disabling deficits, regardless of National Institutes of Health Stroke Scale (NIHSS) score. The benefit of IVT in pa

E Elise K Kristensen

Cardiovascular Prevention and the Implementation Gap in GLP-1 Receptor Agonist Therapies: After the Trials

No abstractJ Am Coll Cardiol. 2026 Aug 11;88(6):710-712. doi: 10.1016/j.jacc.2026.06.024.NO ABSTRACTPMID:42583991 | DOI:10.1016/j.jacc.2026.06.024

J John Erhabor

Tipping the Scale Away From Body Mass Index?: Waist-Based Measures of Adiposity and Cardiovascular Disease Risk

No abstractJ Am Coll Cardiol. 2026 Aug 11;88(6):685-687. doi: 10.1016/j.jacc.2026.05.034.NO ABSTRACTPMID:42583990 | DOI:10.1016/j.jacc.2026.05.034

K Kershaw V Patel

Risk Reclassification Beyond BMI by Waist Circumference and Waist-to-Hip Ratio Across 9 Cardiovascular Outcomes: Results From the Cross-Cohort Collaboration

J Am Coll Cardiol. 2026 Aug 11;88(6):670-684. doi: 10.1016/j.jacc.2026.05.050.ABSTRACTBACKGROUND: Body mass index (BMI) is commonly used to assess total adiposity, yet does not provide insight into overall body composition, potentially obscuring meaningful heterogeneity in cardiovascular disease (CV

Z Zeina A Dardari

Effectiveness of pharmacogenomics-guided dosing in improving treatment outcomes

Indian J Pharmacol. 2026 Jul 1;58(4):332-341. doi: 10.4103/ijp.ijp_1292_25. Epub 2026 Jul 1.ABSTRACTThe pharmacogenomics (PGx) discipline has played the pivotal role in the precision medicine by enabling the tailoring drug therapies to the genomic characteristics on an individual patient. This study

L L V Karthikeyan

Combined use of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors for cardiovascular protection

Indian J Pharmacol. 2026 Jul 1;58(4):293-306. doi: 10.4103/ijp.ijp_1384_25. Epub 2026 Jul 1.ABSTRACTAmong the various treatments for type 2 diabetes during the initial period, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter 2 (SGLT2) inhibitors have been consid

S Soumya Shanta Mohanty

Management of cardiometabolic diseases among tribal populations in South Asia: a scoping review protocol

JBI Evid Synth. 2026 Aug 12. doi: 10.11124/JBIES-26-00116. Online ahead of print.ABSTRACTOBJECTIVE: This scoping review will systematically map and describe evidence on cardiometabolic disease management in and for South Asian tribal (Indigenous) populations and identify key knowledge gaps to inform

K Kaushik Chattopadhyay